Search - tctmd.com

Displaying 341 - 360 of 747

Sort: Relevancy | Date

News Industry News

Biosensors Launches Larger 4.0 x 9mm Axxess™ Size, utilized in Live Left Main case from Sau Paulo

October 31, 2013

Presentation TCT 2013

Case II: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Presenter: Lisette Okkels Jensen

October 30, 2013

Presentation TCT 2013

Assessment of Late Stent Complications with Intravascular Imaging: Restenosis, Late Stent Malapposition, and Very Late Stent Thrombosis

Presenter: Yasuhiro Honda

October 30, 2013

Presentation TCT 2013

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Presenter: Fernando Alfonso

October 30, 2013

News Conference News TCT 2013

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

October 30, 2013

News Industry News

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

October 30, 2013

News Industry News

New Study Examines Safety and Efficacy of Drug Coated Balloon Angioplasty for Treatment of Femoropopliteal Artery Disease

October 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Industry News

Good Outcomes with both Drug-Eluting Stents and Drug-Eluting Balloons in Treating Patients with Bare Metal Stent Restenosis

October 30, 2013

News Industry News

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

October 30, 2013

Presentation TCT 2013

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

Presenter: Bo Xu

October 29, 2013

Presentation TCT 2013

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Presenter: Soo-Jin Kang

October 29, 2013

Presentation TCT 2013

Case Presentation 1: A Long-Run Restenosis Tale

Presenter: Marin Postu

October 29, 2013

News Conference News TCT 2013

Paclitaxel-Coated Balloons Show Promise in Two Studies

October 29, 2013

News Industry News

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

October 29, 2013

Presentation TCT 2013

Restenosis and Stent Thrombosis

Presenter: Kevin Croce

October 28, 2013

Presentation TCT 2013

Longitudinal Stent Deformation and Strut Fracture: Common Causes of Restenosis and Stent Thrombosis?

Presenter: John Ormiston

October 28, 2013

Presentation TCT 2013

Restenosis after Left Main PCI: Frequency, Patterns and Treatment (with Case Vignettes)

Presenter: Adrian Banning

October 28, 2013

Presentation TCT 2013

Predictors of Restenosis and Reocclusion After Successful CTO PCI in the DES Era: Insights from the Florence CTO Registry

Presenter: David Antoniucci

October 28, 2013

Presentation TCT 2013

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Presenter: Bruno Scheller

October 28, 2013

Advertisement

Biosensors Launches Larger 4.0 x 9mm Axxess™ Size, utilized in Live Left Main case from Sau Paulo

Case II: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Assessment of Late Stent Complications with Intravascular Imaging: Restenosis, Late Stent Malapposition, and Very Late Stent Thrombosis

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

New Study Examines Safety and Efficacy of Drug Coated Balloon Angioplasty for Treatment of Femoropopliteal Artery Disease

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Good Outcomes with both Drug-Eluting Stents and Drug-Eluting Balloons in Treating Patients with Bare Metal Stent Restenosis

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Case Presentation 1: A Long-Run Restenosis Tale

Paclitaxel-Coated Balloons Show Promise in Two Studies

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

Restenosis and Stent Thrombosis

Longitudinal Stent Deformation and Strut Fracture: Common Causes of Restenosis and Stent Thrombosis?

Restenosis after Left Main PCI: Frequency, Patterns and Treatment (with Case Vignettes)

Predictors of Restenosis and Reocclusion After Successful CTO PCI in the DES Era: Insights from the Florence CTO Registry

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content